The trademark application EPCORE was filed by AbbVie Biotechnology Ltd, a corporation established under the laws of "BM" (the "Applicant"). The application was published for oppositions on July 15, 2021, and it was registered by office on October 22, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on February 27, 2022.